Sign in

CIK 0001808898

  • Non-accelerated filer
  • Smaller reporting company

Benitec Biopharma Inc.

Sign in to watch
Ticker
BNTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-780-0819
Business address
3940 TRUST WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-18 Banks Jerel A. Chief Executive Officer Grant or award · Options (right to buy) +450,000 450,000
2024-12-09 Banks Jerel A. Chief Executive Officer Grant or award · Options (right to buy) +2,310,000 2,310,000
2024-03-06 Banks Jerel A. Chief Executive Officer Grant or award · Options (right to buy) +466,554 466,554
2023-06-13 Banks Jerel A. Chief Executive Officer Grant or award · Options (right to buy) +356,900 356,900
2020-12-09 Banks Jerel A. Chief Executive Officer Grant or award · Options (right to buy) +284,345 284,345

Page 1 of 1 · 5 trades